当前位置: X-MOL 学术Lancet HIV › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
No excuses left to delay opioid agonist treatment roll-out.
The Lancet HIV ( IF 12.8 ) Pub Date : 2019-12-23 , DOI: 10.1016/s2352-3018(19)30409-6
Ruslan Malyuta 1 , Reinhard M Krausz 2
Affiliation  

Eastern Europe is a long way off achieving targets of the 2016 Political Declaration on HIV and AIDS. The epidemic keeps growing, with no indication of a decline, even after introduction of effective prevention and treatment, including pre-exposure prophylaxis among key populations, as has been seen in western Europe. Most new HIV cases in eastern Europe and central Asia are in Russia and Ukraine, with key populations, including people who inject drugs, remaining the hardest hit.

中文翻译:

没有任何借口延迟阿片类激动剂治疗的推出。

东欧距离实现2016年《关于艾滋病毒和艾滋病的政治宣言》的目标还有很长的路要走。即使在采取了有效的预防和治疗措施后(包括在关键人群中进行接触前的预防),这种流行病仍在继续增长,没有迹象表明其下降,这在西欧已经看到。东欧和中亚的大多数新的艾滋病毒病例都在俄罗斯和乌克兰,主要人群,包括注射毒品的人,受灾最重。
更新日期:2020-02-04
down
wechat
bug